New York State Common Retirement Fund
SGMT icon

New York State Common Retirement Fund’s Sagimet Biosciences SGMT Stock Holding History

New York State Common Retirement Fund’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-195
Closed -$667 – 3318
2024
Q2 		$667 Sell
195
-6,148
-97% -$28.2K ﹤0.01% 3312
2024
Q1 		$34.4K Sell
6,343
-14
-0.2% -$101 ﹤0.01% 3072
2023
Q4 		$34.5K Hold
6,357
– – ﹤0.01% 3078
2023
Q3 		$55.9K Buy
+6,357
New +$84.6K ﹤0.01% 2988

Other funds holding SGMT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

New York State Common Retirement Fund's SGMT Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Sagimet Biosciences (SGMT) in Q3 2024, closing a stake of 195 shares — an estimated $667 sold.

New York State Common Retirement Fund first reported a position in SGMT in Q3 2023 and held it in 4 quarters. The position peaked at $55.9K in Q3 2023. 63 funds tracked by Wall St. Rank hold SGMT as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Sagimet Biosciences position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 195 Sagimet Biosciences shares in Q3 2024, an estimated $667.
  • New York State Common Retirement Fund first reported a position in Sagimet Biosciences in Q3 2023 and held it in 4 quarters.
  • New York State Common Retirement Fund's Sagimet Biosciences position peaked at $55.9K in Q3 2023.
  • 63 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.